INJ is built to absorb institutional demand
Major players do not want inflationary tokens.
They want a rare asset, with real utility and a predictable model.
Injective ticks all the boxes.
The rest is just noise.
Disclaimer: Includes third-party opinions. No financial advice. May include sponsored content. See T&Cs.
INJ
5.66
+0.17%
221
0